AZZ Inc. (AZZ) Reaches $42.70 52-Week Low; Shorts at SANTHERA PHARM HOLDING (SPHDF) Raised By 1.21%

February 11, 2018 - By Kurt Siggers

SANTHERA PHARM HOLDING (OTCMKTS:SPHDF) had an increase of 1.21% in short interest. SPHDF’s SI was 176,000 shares in February as released by FINRA. Its up 1.21% from 173,900 shares previously. With 300 avg volume, 587 days are for SANTHERA PHARM HOLDING (OTCMKTS:SPHDF)’s short sellers to cover SPHDF’s short positions. It closed at $30.91 lastly. It is down 0.00% since February 11, 2017 and is . It has underperformed by 16.70% the S&P500.

The stock of AZZ Inc. (NYSE:AZZ) hit a new 52-week low and has $40.14 target or 6.00% below today’s $42.70 share price. The 7 months bearish chart indicates high risk for the $1.11B company. The 1-year low was reported on Feb, 11 by Barchart.com. If the $40.14 price target is reached, the company will be worth $66.54M less. The stock increased 2.40% or $1 during the last trading session, reaching $42.7. About 210,038 shares traded or 41.37% up from the average. AZZ Inc. (NYSE:AZZ) has declined 1.54% since February 11, 2017 and is downtrending. It has underperformed by 18.24% the S&P500.




Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, engages in the development and commercialization of products for the treatment of mitochondrial and neuromuscular diseases in the areas of various orphan and niche indications in the European Union and internationally. The company has market cap of $184.29 million. It offers Raxone for the treatment of LeberÂ’s hereditary optic neuropathy and Duchenne muscular dystrophy. It currently has negative earnings. The firm is also developing Raxone, which is in Phase II trial for the treatment of patients with primary progressive multiple sclerosis; and omigapil that is in Phase I trial for the treatment of congenital muscular dystrophies.

AZZ Inc. provides galvanizing services, welding solutions, specialty electrical equipment, and highly engineered services to the power generation, transmission, distribution, refining, and industrial markets. The company has market cap of $1.11 billion. The firm operates through two divisions, Energy and Galvanizing Services. It has a 21.68 P/E ratio. The Energy segment provides specialized services and products designed to support industrial, nuclear, and electrical applications.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: